Invesco Dynamic Biotechnology Etf Profile

PBE Etf  USD 66.26  0.54  0.82%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Below Average

 
High
 
Low
Invesco Dynamic is trading at 66.26 as of the 24th of March 2025, a 0.82 percent increase since the beginning of the trading day. The etf's lowest day price was 65.21. Invesco Dynamic has about a 39 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
The fund generally will invest at least 90 percent of its total assets in securities that comprise the underlying index. Dynamic Biotechnology is traded on NYSEARCA Exchange in the United States. More on Invesco Dynamic Biotechnology

Moving together with Invesco Etf

  0.83XBI SPDR SP BiotechPairCorr

Moving against Invesco Etf

  0.43IGA Voya Global AdvantagePairCorr
  0.31GDXU MicroSectors Gold MinersPairCorr

Invesco Etf Highlights

ChairmanH Bond
Thematic Ideas
(View all Themes)
Old NamePowershares Dynamic Biotech & Genome Portfolio
Business ConcentrationHealth Care ETFs, Sector ETFs, Health, Invesco (View all Sectors)
IssuerInvesco
Inception Date2005-06-23
BenchmarkDynamic Biotech & Genome Intellidex Index
Entity TypeRegulated Investment Company
Asset Under Management241.42 Million
Average Trading Valume7,787.9
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorThe Bank of New York Mellon Corporation
AdvisorInvesco Capital Management LLC
CustodianThe Bank of New York Mellon Corporation
DistributorInvesco Distributors, Inc.
Portfolio ManagerPeter Hubbard, Michael Jeanette, Pratik Doshi, Tony Seisser
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End30-Apr
ExchangeNYSE Arca, Inc.
Number of Constituents34.0
Market MakerCitadel
Total Expense0.58
Management Fee0.5
Country NameUSA
Returns Y T D(0.4)
NameInvesco Dynamic Biotechnology Genome ETF
Currency CodeUSD
Open FigiBBG000DTFST2
In Threey Volatility17.42
1y Volatility15.41
200 Day M A68.2956
50 Day M A67.5218
CodePBE
Updated At24th of March 2025
Currency NameUS Dollar
Invesco Dynamic Biotechnology [PBE] is traded in USA and was established 2005-06-23. The fund is classified under Health category within Invesco family. The entity is thematically classified as Health Care ETFs. Invesco Dynamic Biot at this time have 228.48 M in assets. , while the total return for the last 3 years was 2.6%.
Check Invesco Dynamic Probability Of Bankruptcy

Geographic Allocation (%)

Top Invesco Dynamic Biotechnology Etf Constituents

NBIXNeurocrine BiosciencesStockHealth Care
SGMOSangamo TherapeuticsStockHealth Care
BMYBristol Myers SquibbStockHealth Care
VRTXVertex PharmaceuticalsStockHealth Care
BIIBBiogen IncStockHealth Care
CORTCorcept Therapeutics IncorporatedStockHealth Care
PTCTPTC TherapeuticsStockHealth Care
MYGNMyriad GeneticsStockHealth Care
More Details

Invesco Dynamic Biot Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Invesco Dynamic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

Invesco Dynamic Against Markets

When determining whether Invesco Dynamic Biot is a strong investment it is important to analyze Invesco Dynamic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Invesco Dynamic's future performance. For an informed investment choice regarding Invesco Etf, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Invesco Dynamic Biotechnology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
The market value of Invesco Dynamic Biot is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Dynamic's value that differs from its market value or its book value, called intrinsic value, which is Invesco Dynamic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Dynamic's market value can be influenced by many factors that don't directly affect Invesco Dynamic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Dynamic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Dynamic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Dynamic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.